1,2-dipalmitoylphosphatidylcholine has been researched along with Triple Negative Breast Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doolittle, E; Doron, G; Goldberg, A; Govender, P; Karathanasis, E; Lee, Z; Peiris, PM; Rao, S; Schiemann, WP; Shah, S; Sylvestre, M; Tucci, S; Turan, O | 1 |
1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Triple Negative Breast Neoplasms
Article | Year |
---|---|
Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Cell Line, Tumor; Cholesterol; Diagnostic Imaging; Drug Compounding; Drug Delivery Systems; Female; Gene Expression; Humans; Integrin alphaVbeta3; Lung Neoplasms; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Transplantation; P-Selectin; Protein Binding; Recombinant Proteins; Triple Negative Breast Neoplasms | 2015 |